Radiolabelling of poly(histidine) derivatized biodegradable microspheres with the re tricarbonyl complex [re(co)3(h2o)3]+

Nuclear Medicine Communications

Volumn 26, Issue 5, 2005, Pages 453-458

  Yu, Junfeng ^a   Häfeli, Urs O ^b   Xia, Jiaoyun ^b   Li, Shiqiang ^b   Dong, Mo ^b   Yin, Duanzhi ^b   Wang, Yongxian ^b  

^a SHANGHAI INSTITUTE OF APPLIED PHYSICS   (China)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Histidine; Microsphere; Radiation synovectomy; Radiolabelling; Tricarbonyl

Indexed keywords

MICROSPHERE; POLYLACTIC ACID; POLYLACTIC ACID HISTIDINE TRICARBONYL COMPLEX RE 188; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ARTICLE; BRACHYTHERAPY; CHELATION; DRUG STABILITY; DRUG SYNTHESIS; ISOTOPE LABELING; RADIOACTIVITY; SYNOVECTOMY;

ARTHRITIS; BIOCOMPATIBLE MATERIALS; BRACHYTHERAPY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, THIN LAYER; COLLOIDS; HISTIDINE; HUMANS; INFLAMMATION; MICROSPHERES; QUALITY CONTROL; RADIOISOTOPES; RADIOPHARMACEUTICALS; RHENIUM; TEMPERATURE; TIME FACTORS;

EID: 18244402382     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200505000-00010     Document Type: Article

References (22)

1. 166Ho-EDTMP-HA. Nuclear Techniques 1997; 20:691-695.
2. Chinol M, Vallabhajosula S, Goldsmith SJ, Klein MJ, Deutsch KF, Chinen LK, et al. Chemistry and biological behavior of samarium-153 and rhenium-186-labeled hydroxyapatite particles: Potential radiopharmaceuticals for radiation synovectomy. J Nucl Med 1993; 34:1536-1542.
3. Edmonds J, Smart R, Laurent R, Butler P, Brooks P, Hoschl R, et al. A comparative study of the safety and efficacy of dysprosium-165 hydroxide macro-aggregate and yttrium-90 silicate colloid in radiation synovectomy - A multicentre double blind clinical trial. Br J Rheumatol 1994; 33:947-953.
4. Grillenberger KG, Glatz S, Reske SN. Rhenium-188 labeled hydroxyapatite and rhenium-188 sulfur colloid. Nuklearmedizin 1997; 36:71-75.
5. Gobel D, Gratz S, Rothkirch VT, Beckr W, Willert HG. Radiosynoviorthesis with rhenium-186 in rheumatoid arthritis: a prospective study of three regimes. Rheumatol Int 1997; 17:105-108.
6. Jeong JM, Lee YJ, Kim YJ, Chang YS, Lee DS, Chung JK, et al. Preparation of rhenium-188-tin colloid as a radiation synovectomy agent and comparison with rhenium-188-sulfur colloid. Appl Radiat Isot 2000; 52:851-855.
7. Merchan ECR, Magallon M, Martin-Villar J, Galindo E, Ortega F, Pardo JA. Long term follow up of haemophilic arthropathy treated by Au-198 radiation synovectomy. Int Orthop 1993; 17:120-124.
8. Knapp FF Jr. Rhenium-188 - a generator-derived radioisotope for cancer therapy. Cancer Biother Radiopharm 1998; 13:337-349.
9. Wang SJ, Lin WY, Chen MN, Hsieh BT, Shen LH, Tsai ZT, et al. Rhenium-188 microspheres: A new radiation synovectomy agent. Nucl Med Commun 1998; 19:427-433.
10. Wang SJ, Lin WY, Hsieh BT, Shen LH, Tsai ZT, Ting G, et al. Rhenium-188 sulphur colloid as a radiation synovectomy agent. Eur J Nucl Med 1995; 22:505-507.
11. Venkatesan PP, Shortkroff S, Zalutsky MR, Sledge CB. Rhenium heptasulfide: a potential carrier system for radiation synovectomy. Nucl Med Biol, Int J Radiat Applications Instrum Part B 1990; 17:357-362.
12. 188Re-sulfide suspension for radiation synovectomy. Chin J Nucl Med 1999; 19:122.
13. Schibli R, Schubiger PA. Current use and future potential of organometallic radiopharmaceuticals. Eur J Nucl Med Mol Imaging 2002; 29:1529-1542.
14. + (M=Re, Tc) directed towards radiopharmaceutical applications. Coordination Chemistry Reviews 1999; 190-192:901-919.
15. + and synthesis of tailor-made bifunctional ligand systems. Bioconjugate Chem 2002; 13:750-756.
16. +. Bioconjug Chem 2004; (submitted).
17. Yu JF, Duanzhi Y, Xiaofeng M, Zili G, Jiong Z, Yongxian W, et al. [Re-188] Rhenium sulfide suspension: A potential radiopharmaceutical for tumor treatment following intra-tumor injection. Nucl Med Biol 1999; 26:573-579.
18. 12]. Chem Commun 1996; 11:1291-1292.
19. 188Re-tricarbonyl preparation for high specific activity labeling of biomolecules. J Label Comp Radiopharm 2001; 44:S723-S725.
20. + core. Appl Radiat Isot 2004; (submitted).
21. Georgiades CS, Ramsey DE, Solomon S, Geschwind JF. New nonsurgical therapies in the treatment of hepatocellular carcinoma. Tech Vasc Interv Radiol 2001; 4:193-199.
22. Häfeli UO. Radiolabeled magnetic microcapsules for magnetically targeted radionuclide therapy. In: Arshady R (editor): Microspheres, Microcapsules & Liposomes: Radiolabeled and Magnetic Particulates in Medicine and Biology. London: Citus Books; 2001, pp. 559-584.